The novel treatment of this peptide represents a significant advance in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide429294.pages10.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-77530965